$771 Million is the total value of Logos Global Management LP's 47 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CYTK | Buy | CYTOKINETICS INC | $59,448,000 | -1.6% | 1,615,000 | +21.9% | 7.71% | +23.7% |
| ALXO | Buy | ALX ONCOLOGY HLDGS INC | $50,892,000 | -18.5% | 3,011,352 | +3.6% | 6.60% | +2.4% |
| APLS | Sell | APELLIS PHARMACEUTICALS INC | $45,729,000 | -3.3% | 900,000 | -10.0% | 5.93% | +21.6% |
| DSGN | Buy | DESIGN THERAPEUTICS INC | $45,180,000 | -23.9% | 2,797,501 | +0.9% | 5.86% | -4.3% |
| NBIX | New | NEUROCRINE BIOSCIENCES INC | $44,531,000 | – | 475,000 | +100.0% | 5.77% | – |
| GBT | Buy | GLOBAL BLOOD THERAPEUTICS IN | $43,300,000 | +97.2% | 1,250,000 | +66.7% | 5.61% | +148.0% |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $43,109,000 | +9.7% | 340,000 | +13.3% | 5.59% | +37.9% |
| BCYC | Buy | BICYCLE THERAPEUTICS PLCsponsored ads | $41,686,000 | -21.3% | 950,000 | +9.2% | 5.40% | -1.0% |
| Buy | VENTYX BIOSCIENCES INC | $34,119,000 | -5.8% | 2,514,280 | +37.8% | 4.42% | +18.4% | |
| IDYA | Buy | IDEAYA BIOSCIENCES INC | $31,892,000 | -13.0% | 2,850,000 | +83.9% | 4.14% | +9.4% |
| ISEE | Buy | IVERIC BIO INC | $30,294,000 | +39.4% | 1,800,000 | +38.5% | 3.93% | +75.2% |
| ARQT | Buy | ARCUTIS BIOTHERAPEUTICS INC | $28,890,000 | +457.2% | 1,500,000 | +500.0% | 3.75% | +600.2% |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $28,777,000 | +292.3% | 350,000 | +600.0% | 3.73% | +393.5% |
| KZR | Buy | KEZAR LIFE SCIENCES INC | $26,825,000 | +10.6% | 1,614,021 | +11.3% | 3.48% | +39.1% |
| Sell | DICE THERAPEUTICS INC | $26,500,000 | -37.1% | 1,385,251 | -16.8% | 3.44% | -20.9% | |
| DYN | Sell | DYNE THERAPEUTICS INC | $26,360,000 | -31.5% | 2,734,392 | -15.5% | 3.42% | -13.8% |
| FULC | Buy | FULCRUM THERAPEUTICS INC | $23,650,000 | +95.2% | 1,000,000 | +46.0% | 3.07% | +145.3% |
| ASND | New | ASCENDIS PHARMA A/Ssponsored adr | $20,538,000 | – | 175,000 | +100.0% | 2.66% | – |
| IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $16,650,000 | – | 1,000,000 | +100.0% | 2.16% | – |
| OLMA | OLEMA PHARMACEUTICALS INC | $15,949,000 | -54.5% | 3,743,875 | 0.0% | 2.07% | -42.8% | |
| ATHA | Sell | ATHIRA PHARMA INC | $9,683,000 | -54.4% | 717,285 | -56.0% | 1.26% | -42.7% |
| JNCE | Buy | JOUNCE THERAPEUTICS INC | $9,506,000 | -15.7% | 1,400,000 | +3.7% | 1.23% | +5.9% |
| VERA | Buy | VERA THERAPEUTICS INCcl a | $9,044,000 | +576.9% | 385,000 | +670.0% | 1.17% | +750.0% |
| SRRK | New | SCHOLAR ROCK HLDG CORP | $8,701,000 | – | 675,000 | +100.0% | 1.13% | – |
| ANAB | New | ANAPTYSBIO INC | $7,422,000 | – | 300,000 | +100.0% | 0.96% | – |
| IPSC | Sell | CENTURY THERAPEUTICS INC | $6,928,000 | -28.9% | 550,259 | -10.4% | 0.90% | -10.6% |
| CNTA | CENTESSA PHARMACEUTICALS PLCsponsored ads | $4,077,000 | -20.3% | 454,545 | 0.0% | 0.53% | +0.2% | |
| TIL | New | INSTIL BIO INC | $4,054,000 | – | 377,091 | +100.0% | 0.53% | – |
| TALS | Sell | TALARIS THERAPEUTICS INC | $3,013,000 | -40.1% | 306,236 | -6.9% | 0.39% | -24.7% |
| Sell | TYRA BIOSCIENCES INC | $2,704,000 | -59.4% | 252,726 | -46.6% | 0.35% | -48.9% | |
| VERV | Sell | VERVE THERAPEUTICS INC | $2,212,000 | -86.5% | 96,912 | -78.1% | 0.29% | -83.0% |
| CGEM | Sell | CULLINAN ONCOLOGY INC | $2,094,000 | -52.9% | 200,000 | -30.7% | 0.27% | -41.0% |
| EWTX | Sell | EDGEWISE THERAPEUTICS INC | $2,073,000 | -84.0% | 213,744 | -74.9% | 0.27% | -79.9% |
| SPRB | Sell | SPRUCE BIOSCIENCES INC | $2,010,000 | -59.0% | 1,000,000 | -9.1% | 0.26% | -48.4% |
| NUVALENT INC | $1,870,000 | -27.0% | 134,650 | 0.0% | 0.24% | -8.3% | ||
| LIANBIOsponsored ads | $1,532,000 | -39.8% | 412,837 | 0.0% | 0.20% | -24.0% | ||
| VRNA | Buy | VERONA PHARMA PLCsponsored ads | $1,497,000 | +82.6% | 300,000 | +145.9% | 0.19% | +128.2% |
| New | VIGIL NEUROSCIENCE INC | $1,445,000 | – | 205,595 | +100.0% | 0.19% | – | |
| VTGN | Sell | VISTAGEN THERAPEUTICS INC | $1,240,000 | -68.2% | 1,000,000 | -50.0% | 0.16% | -60.0% |
| PYXIS ONCOLOGY INC | $1,158,000 | -63.2% | 286,652 | 0.0% | 0.15% | -53.7% | ||
| COGT | COGENT BIOSCIENCES INC | $1,124,000 | -12.7% | 150,000 | 0.0% | 0.15% | +9.8% | |
| IKNA | Sell | IKENA ONCOLOGY INC | $1,088,000 | -71.1% | 178,281 | -40.5% | 0.14% | -63.7% |
| BMEA | Sell | BIOMEA FUSION INC | $892,000 | -52.5% | 200,000 | -20.7% | 0.12% | -40.2% |
| Sell | SOMALOGIC INC | $802,000 | -65.6% | 100,000 | -50.1% | 0.10% | -56.8% | |
| RAIN | Sell | RAIN THERAPEUTICS INC | $680,000 | -78.5% | 134,194 | -45.3% | 0.09% | -73.0% |
| Sell | OMEGA THERAPEUTICS INC | $81,000 | -91.9% | 12,986 | -85.3% | 0.01% | -89.3% | |
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $54,000 | -57.1% | 66,666 | 0.0% | 0.01% | -46.2% | |
| MREO | Exit | MEREO BIOPHARMA GROUP PLCads | $0 | – | -46,984 | -100.0% | -0.01% | – |
| Exit | ADAGIO THERAPEUTICS INC | $0 | – | -70,000 | -100.0% | -0.05% | – | |
| DAWN | Exit | DAY ONE BIOPHARMACEUTICALS I | $0 | – | -37,069 | -100.0% | -0.06% | – |
| Exit | MARINUS PHARMACEUTICALS INC | $0 | – | -130,000 | -100.0% | -0.16% | – | |
| WVE | Exit | WAVE LIFE SCIENCES LTD | $0 | – | -800,000 | -100.0% | -0.26% | – |
| TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.32% | – |
| JANX | Exit | JANUX THERAPEUTICS INC | $0 | – | -185,196 | -100.0% | -0.38% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.42% | – |
| GRPH | Exit | GRAPHITE BIO INC | $0 | – | -406,308 | -100.0% | -0.52% | – |
| FATE | Exit | FATE THERAPEUTICS INC | $0 | – | -94,000 | -100.0% | -0.57% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -350,000 | -100.0% | -0.59% | – |
| ELDN | Exit | ELEDON PHARMACEUTICALS INC | $0 | – | -1,339,793 | -100.0% | -0.61% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -35,000 | -100.0% | -0.61% | – |
| LABP | Exit | LANDOS BIOPHARMA INC | $0 | – | -1,375,000 | -100.0% | -0.68% | – |
| CMPS | Exit | COMPASS PATHWAYS PLCsponsored ads | $0 | – | -300,000 | -100.0% | -0.68% | – |
| FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -625,000 | -100.0% | -0.74% | – |
| NGM | Exit | NGM BIOPHARMACEUTICALS INC | $0 | – | -475,000 | -100.0% | -0.87% | – |
| PTGX | Exit | PROTAGONIST THERAPEUTICS INC | $0 | – | -250,000 | -100.0% | -0.88% | – |
| RLMD | Exit | RELMADA THERAPEUTICS INC | $0 | – | -400,000 | -100.0% | -0.93% | – |
| EPIX | Exit | ESSA PHARMA INC | $0 | – | -865,000 | -100.0% | -1.27% | – |
| KYMR | Exit | KYMERA THERAPEUTICS INC | $0 | – | -200,000 | -100.0% | -1.31% | – |
| HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -1,930,000 | -100.0% | -1.50% | – |
| ALPN | Exit | ALPINE IMMUNE SCIENCES INC | $0 | – | -1,120,000 | -100.0% | -1.60% | – |
| FMTX | Exit | FORMA THERAPEUTICS HLDGS INC | $0 | – | -1,600,000 | -100.0% | -2.35% | – |
| RPTX | Exit | REPARE THERAPEUTICS INC | $0 | – | -1,700,000 | -100.0% | -3.70% | – |
| ALGS | Exit | ALIGOS THERAPEUTICS INC | $0 | – | -3,112,785 | -100.0% | -3.81% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| CYTOKINETICS INC | 14 | Q3 2023 | 12.6% |
| KARUNA THERAPEUTICS INC | 14 | Q3 2023 | 5.6% |
| ALX ONCOLOGY HLDGS INC | 13 | Q3 2023 | 23.3% |
| DYNE THERAPEUTICS INC | 13 | Q3 2023 | 4.9% |
| APELLIS PHARMACEUTICALS INC | 12 | Q3 2023 | 12.4% |
| OLEMA PHARMACEUTICALS INC | 12 | Q3 2023 | 15.4% |
| DESIGN THERAPEUTICS INC | 11 | Q3 2023 | 8.0% |
| NUVATION BIO INC | 11 | Q3 2023 | 0.0% |
| BICYCLE THERAPEUTICS PLC | 10 | Q2 2023 | 5.7% |
| IDEAYA BIOSCIENCES INC | 9 | Q3 2023 | 9.5% |
View Logos Global Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | July 18, 2023 | 6,350,000 | 8.1% |
| BICYCLE THERAPEUTICS plc | February 14, 2023 | 1,435,000 | 4.8% |
| Dyne Therapeutics, Inc. | February 14, 2023 | 2,150,000 | 4.1% |
| Design Therapeutics, Inc. | March 31, 2022 | 2,797,501 | 5.0% |
| IDEAYA Biosciences, Inc. | March 18, 2022 | 2,650,000 | 6.9% |
| Aligos Therapeutics, Inc. | February 14, 2022 | ? | ? |
| Cogent Biosciences, Inc. | February 14, 2022 | 150,000 | 0.4% |
| Kezar Life Sciences, Inc. | February 14, 2022 | 1,450,000 | 3.0% |
| Nkarta, Inc. | February 14, 2022 | ? | ? |
| Viridian Therapeutics, Inc.\DE | February 14, 2022 | ? | ? |
View Logos Global Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G | 2024-04-01 |
| SC 13G | 2024-02-22 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-13 |
| SC 13G/A | 2024-02-13 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-22 |
| SC 13G | 2024-01-02 |
View Logos Global Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.